Safeguard Investment Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
Safeguard Investment Advisory Group's ARKG Position: Q3 2024 in Review
Safeguard Investment Advisory Group sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 10,611 shares — an estimated $246K sold.
Safeguard Investment Advisory Group first reported a position in ARKG in Q4 2020 and held it in 15 quarters. The position peaked at $2.97M in Q2 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.
- Safeguard Investment Advisory Group reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
- Safeguard Investment Advisory Group sold 10,611 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $246K.
- Safeguard Investment Advisory Group first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 15 quarters.
- Safeguard Investment Advisory Group's ARK Genomic Revolution ETF position peaked at $2.97M in Q2 2021.
- 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.
Based on Safeguard Investment Advisory Group's 13F filing for Q3 2024, filed 14 Nov 2024.